Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic Articles uri icon

authors

  • Sanchez de la Nava, Ana Maria
  • GOMEZ CID, LIDIA
  • RIOS MUĂ‘OZ, GONZALO RICARDO
  • Fernandez Santos, Maria Eugenia
  • Fernandez, Ana I.
  • Arenal, Angel
  • Sanz Ruiz, Ricardo
  • Grigorian Shamagian, Lilian
  • Atienza, Felipe
  • Fernandez Aviles, Francisco

publication date

  • September 2022

issue

  • 3

volume

  • 11

International Standard Serial Number (ISSN)

  • 2673-6284

abstract

  • (copyright) 2022 by the authors. Licensee MDPI, Basel, Switzerland.Translational science has been introduced as the nexus among the scientific and the clinical field, which allows researchers to provide and demonstrate that the evidence-based research can connect the gaps present between basic and clinical levels. This type of research has played a major role in the field of cardiovascular diseases, where the main objective has been to identify and transfer potential treatments identified at preclinical stages into clinical practice. This transfer has been enhanced by the intromission of digital health solutions into both basic research and clinical scenarios. This review aimed to identify and summarize the most important translational advances in the last years in the cardiovascular field together with the potential challenges that still remain in basic research, clinical scenarios, and regulatory agencies.

keywords

  • cardiovascular diseases; digital health; translational medicine